Mankind Pharma is an Indian pharmaceutical company incorporated in 1995. It is the self-described 4th largest pharmaceutical company in India by domestic sales, focusing on producing pharmaceutical products.

MANKIND PHARMA LTD

Mankind Pharma Limited

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

Mankind Pharma

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries.

Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products.

Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients.

Mankind strongly believes and follows its Core Values:

𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External
𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products
𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements
𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone
𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities
𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

A tribute to the compassionate heroes who choose to give the gift of life to those in need. #MankindPharma believes that choosing to be an organ donor is an act of spreading kindness. With only 0.86 donors per million, alarmingly low number of registered donors in our country, we urge you to spark a wave of change and choose to be an organ donor today.

Share this video to spread awareness!

#WorldOrganDonationDay #OrganDonation #SpreadingKindness #ServingLife #HealthIsWealth #Mankind #Healthcare #Pharma #Pharmaceutical #Health

Mankind Pharma is pleased to announce its steady performance for this quarter, reflecting our unwavering commitment to innovative healthcare solutions. The company remains focused on expanding to chronic therapies and entering high entry barrier segments with the acquisition of Bharat Serums and Vaccines Limited, to ensure sustained growth and industry leadership.

#MankindPharma #ServingLife

Rajeev Juneja  VC and Managing Director MANKIND PHARMA LTD  In conversation with CNBC-TV18  

BSV’s acquisition marks a pivotal milestone in Mankind’s journey. This strategic partnership solidifies our position as the #1 leader in Gynecology and propels us into a leadership role in women's health and fertility. 

BSV's established Specialty R&D Tech Platforms with complex portfolio across Women’s health, Fertility, critical care and Immunoglobulin segment perfectly aligns with Mankind Pharma's strategic vision to expand its footprint in high entry barrier portfolio.

By combining our strengths, we're creating a formidable force dedicated to delivering innovative solutions and improving the lives of millions.

#MankindPharma #BSVAcquisition #WomensHealth #Fertility #Healthcare #Leadership #Innovation

Watch now:

https://lnkd.in/g85RkxBr

https://lnkd.in/g52ahdYF

For an infection with no known cure,  let’s vow this #WorldHepatitisDay to spread awareness and lower our chances of the deadly infection.

#MankindPharma #ServingLife #SpreadingKindness #HealthIsWealth #Mankind #Healthcare #Pharma #Pharmaceutical #Health

#Budget2024 aligns with #ViksitBharat vision for healthcare. We welcome the focus on medical education, prevention & infrastructure, the allocation for long-term R&D financing for pharma, the bio-manufacturing scheme, and the customs duty exemption for cancer drugs. Overall, a promising direction for a more resilient & accessible healthcare system in India: Mr Arjun Juneja, Chair, FICCI Pharma Committee and COO, MANKIND PHARMA LTD.

#BudgetWithFICCI

In Monsoon, your high fever could be dengue! Skip the guesswork. Stay a step ahead with Rapid News Dengue Home Detection Kit – because hashtag
#MonsoonNahiYeDengueSeasonHai

Buy from your nearest chemist, Apollo Pharmacy, Frank Ross, Amazon, Flipkart & Tata 1 mg. 

#dengue #monsoon #test #detection #testkit #denguekit #season #rain #rapidnewskit #MankindPharma #SevingLife

MANK

COM:MANKINDPHARMA

Mankind Pharma

Last Close

2,551.60

25/11 09:40

Market Cap

848.24B

Beta: -

Volume Today

358.29K

Avg: -

name

homepage url

country

linkedin url

employee count

sector

industry

revenue

Description

invested in

investor of

competitor of

Metrics